Given its involvement in the immune system, regulation of vascular permeability, tumor promotion and progression, the clinical impact of NRP-1 has been extensively studied in cancer, leukemia, autoimmune disease, liver pathologies, kidney injury, and COVID-19. This evidence concerns the gene NRP1 and COVID-19.